Search Results
Aug 28, 2026, 07:00 ET CREATE Medicines Expands Clinical In Vivo CAR Pipeline and LNP Technology Suite by Forming Strategic Collaboration With WestGene
tumors, and durable gene delivery:CRT-403, a dual-target CD19 × BCMA in vivo CAR-T therapy for autoimmune disease that targets both B cells and antibody-producing plasma cells.CRT-401, a dual-component HER2 × TROP2 multi-immune in vivo CAR
More news about: CREATE Medicines, Inc.
Aug 27, 2026, 10:15 ET CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
February 2026 as monotherapy for adults with unresectable Stage III NSCLC whose disease has not progressed following platinum-based chemoradiotherapy (CRT). Meanwhile, marketing authorization applications for sugemalimab have either been approved or are under active review in nearly 30 countries worldwide.In
More news about: CStone Pharmaceuticals
Aug 21, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES AUGUST CASH DISTRIBUTION
Aug. 21, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.067892 per unit, payable on September 15, 2026, to unitholders
More news about: Cross Timbers Royalty Trust
Jul 30, 2026, 07:00 ET CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases
CRT-402 is a CD19-targeted, in vivo CAR-T therapy that reprograms a patient's own T cells directly within the body to deplete autoreactive B cells and drive disease into remission. Because it works in vivo, CRT-402 removes the need for the ex vivo cell manufacturing
More news about: CREATE Medicines, Inc.
Jul 21, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION
July 21, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.061397 per unit, payable on August 14, 2026, to unitholders
More news about: Cross Timbers Royalty Trust
Jul 20, 2026, 16:01 ET AGNC Investment Corp. Announces Second Quarter 2026 Financial Results
MBS")$9.7 billion net forward purchases/(sales) of Agency MBS in the "to-be-announced" market ("TBA securities")$0.7 billion credit risk transfer ("CRT") and non-Agency securities and other mortgage credit investments7.4x tangible net book value "at risk" leverage as of June 30, 2026
More news about: AGNC Investment Corp.
Jul 18, 2026, 14:55 ET REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
from baseline in BCVA at 54 weeks and one year, respectively. Secondary endpoints include safety and tolerability, change in central retinal thickness (CRT) and need for supplemental anti-VEGF injections in the treatment arms. Together, these pivotal studies have enrolled over 1,200 participants across more
More news about: REGENXBIO Inc.
Jul 17, 2026, 17:25 ET SIGGRAPH 2026 Puts AI to Work as a Creative Partner Across Research, Art, and Industry
"Diffusion TV" by Sihwa Park with York University demystifies AI diffusion models through a nostalgic CRT television. By turning the set's knobs and antenna, viewers move across three channels: extinct animals of the past, endangered species of the present,
More news about: SIGGRAPH 2026
Jul 14, 2026, 01:51 ET Waton Financial to Bring MoTA's Multi-Agent Investment Platform to Individual Investors
marketplace by late 2026.Why Pixel ArtMoTA's visual identity draws on 8-bit pixel art, featuring neon green against deep purple, CRT-style scan lines, and typefaces reminiscent of a 1990s Game Boy. It is an unconventional choice for a financial product."Most fintech apps use
More news about: Waton Financial
Jun 25, 2026, 05:44 ET CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand
≥1% of tumor cells and no sensitising EGFR mutations, or ALK, ROS1 genomic aberrations and whose disease has not progressed following platinum-based CRT.The National Medical Products Administration (NMPA) of China has approved sugemalimab for five indications:In combination
More news about: CStone Pharmaceuticals
Jun 18, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION
June 18, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.044186 per unit, payable on July 15, 2026, to unitholders
More news about: Cross Timbers Royalty Trust
Jun 09, 2026, 10:25 ET I-CAR CHAMPIONS THE NEXT GENERATION OF COLLISION REPAIR PROFESSIONALS AT SKILLSUSA 2026
well beyond its booth. Members of I-CAR's team and instructor network volunteered their time and expertise to execute the Collision Repair Technology (CRT) competitions—evaluating the next generation of technicians against the same rigorous standards that define professional excellence in the field."SkillsUSA
More news about: I-CAR
May 29, 2026, 11:26 ET WTWH Healthcare Announces the Future Leaders Class of 2026
aging and healthcare. Honorees represent a wide range of sectors, including ambulatory surgery centers, behavioral health, complex rehab technology (CRT), home health & home care, home medical equipment (HME), hospice & palliative care, senior housing & senior living, and skilled nursing."The
More news about: WTWH Media
May 21, 2026, 18:51 ET SIGGRAPH 2026 Explores the Convergence of Art, Science, and Technology
Diffusion TV: An interactive interface that aims to demystify the inner workings of AI diffusion models through a nostalgic CRT TV. By manipulating the TV's knobs and antenna, viewers explore AI-generated images and sounds, experiencing the transformation of chaotic data into
More news about: SIGGRAPH 2026
May 18, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION
May 18, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.029624 per unit, payable on June 12, 2026, to unitholders
More news about: Cross Timbers Royalty Trust
May 18, 2026, 08:00 ET EmStop™ Announces Initiation of CAPTURE-2 IDE Clinical Trial
results of the CAPTURE-1 early feasibility clinical study, first published and presented in March 2025 at the Cardiovascular Research Technologies (CRT) meeting in Washington, D.C."Although stroke is a relatively low-incidence event in TAVR, it remains a serious and high-impact complication for
More news about: EmStop
May 14, 2026, 08:10 ET CREATE Medicines Strengthens Clinical and Scientific Advisory Board with Appointment of Georg Schett, MD, Margrit Wiesendanger, MD, PhD, and Christopher Jewell, PhD
that, and I am excited to support the team as they advance CRT-402 to the clinic."CREATE's Scientific Advisory Board are compensated advisors to the company across its autoimmune and oncology programs, including the advancement of CRT-402 toward clinical development. It now includes:Georg
More news about: CREATE Medicines, Inc.
May 14, 2026, 08:00 ET CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology
enabling a rapid, iterative product engine designed to compress concept-to-clinic timelines.In autoimmune, CREATE's lead program CRT-402, a next generation CD19 targeted in vivo CAR-T therapy, has demonstrated deep and durable B cell depletion in non-human primates, with the potential
More news about: CREATE Medicines, Inc.
May 04, 2026, 06:45 ET IGT Presents Powerful Combination of Gaming and FinTech Solutions at G2E Asia 2026
with multiple CMSs will be a centerpiece of IGT's G2E Asia showcase. The award-winning Everi Premium Cash Redemption Terminal ("CRT") and the Everi Mini CRT bring friction-free transactions to the gaming floor and introduce convenient tap functionality. IGT will also exhibit Everi QuickDraw™,
More news about: IGT
Apr 20, 2026, 16:01 ET AGNC Investment Corp. Announces First Quarter 2026 Financial Results
MBS")$9.5 billion net forward purchases/(sales) of Agency MBS in the "to-be-announced" market ("TBA securities")$0.7 billion credit risk transfer ("CRT") and non-Agency securities and other mortgage credit investments7.4x tangible net book value "at risk" leverage as of March 31, 2026
More news about: AGNC Investment Corp.
Apr 20, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUST DECLARES APRIL CASH DISTRIBUTION
April 20, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.069720 per unit, payable on May 14, 2026, to unitholders
More news about: Cross Timbers Royalty Trust
Apr 07, 2026, 13:11 ET LATINAS IN LEADERSHIP™ Inc. ANNOUNCES REBRAND AND 23RD SYMPOSIUM, FEATURING CIVIL RIGHTS LEADER DOLORES HUERTA
Eversource, The Hartford Insurance, Hartford H ealthcare and MassMutual. Our partnerships includeUniversity of CT, Puerto Rican Research Institute, CRT of CT, Metro Hartford Alliance, Leadership Greater Hartford and United Way. Media Support comes from CT. Public Television and En Lente TV.About
More news about: Latinas in Leadership Inc.
Apr 06, 2026, 01:17 ET Vale Base Metals Menyampaikan Hasil Eksplorasi 2025 dan Hasil Prospek 2026; Cadangan Mineral dan Sumber Daya Mineral Tembaga Meningkat 6% menjadi 53 juta ton
m @0,76% dari 390 m, termasuk 13 m @ 1,05% Cu dari 432 m75 m @ 1,34% Cu dari 596 m, termasuk 11 m @ 2,71% Cu dari 609 m (lubang bor CRT-CRTS-DH00001)
More news about: Vale Base Metals
Apr 01, 2026, 14:19 ET Vale Base Metals publica los resultados de exploración de 2025 y las perspectivas para 2026
incluyendo 13 m con 1,05 % de Cu desde 432 m75 m con 1,34 % de Cu desde 596 m, incluyendo 11 m con 2,71 % de Cu desde 609 m (perforación CRT-CRTS-DH00001)
More news about: Vale Base Metals
Mar 30, 2026, 22:57 ET Vale Base Metals gibt Explorationsergebnisse für 2025 und Ausblick für 2026 bekannt; Kupfermineralreserven und -ressourcen steigen um 6% auf 53 Millionen Tonnen
123m55m @0,76% von 390 Mio., einschließlich 13 Mio. @ 1,05% Cu aus 432m75m @ 1,34% Cu aus 596m, inkl. 11m @ 2,71% Cu aus 609m (Bohrung CRT-CRTS-DH00001)
More news about: Vale Base Metals